|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Feb―17 |
Blood transcriptome analysis uncovered COVID-19-myocarditis crosstalk |
Shuang Liang, Ying-Ying Zheng, Ying Pan |
2 |
[GO] |
2024―Feb―01 |
Description of nasopharyngeal bacterial pathogens associated with different SARS-CoV-2 variants |
Ornella La Fortune Tchoupou Saha, Grégory Dubourg, Abdourahamane Yacouba, Raphael Tola, Didier Raoult, Jean-Christophe Lagier |
3 |
[GO] |
2024―Jan―23 |
Soluble Endoglin and Syndecan-1 levels predicts the clinical outcome in COVID-19 patients |
Remya Rajan, Mohamed Hanifah, Vignesh Mariappan, Monica Anand, Agieshkumar Balakrishna Pillai |
4 |
[GO] |
2023―Nov―21 |
Insights into the evolution of mutations in SARS-CoV-2 non-spike proteins |
Rimanshee Arya, Preeti Tripathi, Karthik Nayak, Janani Ganesh, Subhash C. Bihani, Biplab Ghosh, et al. (+2) Vishal Prashar, Mukesh Kumar |
5 |
[GO] |
2023―Nov―13 |
Basal cell carcinoma is causally associate with the increased COVID-19 susceptibility and hospitalization |
Peixin Dong, Wenjie Li, Yanbin Zhou |
6 |
[GO] |
2023―Okt―21 |
Latent toxoplasmosis in COVID-19 patients and link with higher mortality in COVID-19 male patients |
Mohammad Reza Mahmoudi, Saadat Farshid, Tofigh Yaghubi Kalurazi, Faezeh Aliverdilou, Panagiotis Karanis |
7 |
[GO] |
2023―Okt―19 |
Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19 |
S. Chatterjee, B.S. Sanjeev |
8 |
[GO] |
2023―Okt―14 |
SARS-CoV-2 virus associated angiotensin converting enzyme 2 expression modulation in colorectal cancer: Insights from mRNA and protein analysis COVID-19 associated (ACE2) expression in colorectal cancer |
Mashael Alhumaidi Alotaibi, Tahani Mohamed Ibrahim Al-Hazani, Maha Abdulla Alwaili, Areej Saud Jalal, Dalal S. Alshaya, Fatmah Ahmed Safhi, et al. (+3) Muna O. Alamoudi, Saud Alarifi, Wedad Saeed Al-Qahtani |
9 |
[GO] |
2023―Sep―24 |
Antibiotics and nano-antibiotics in treatment of lung infection: In management of COVID-19 |
Sushant Sunder, Kriti Bhandari, Shruti Sounkaria, Manjari Vyas, Bhupendra Pratap Singh, Prakash Chandra |
10 |
[GO] |
2023―Sep―14 |
Nucleocapsid protein residues 35, 36, and 113 are critical sites in up-regulating the Interleukin-8 production via C/EBPα pathway by highly pathogenic porcine reproductive and respiratory syndrome virus |
Xingyu Gong, Tianyi Ma, Jingjing Wang, Xinran Cao, Qiaoya Zhang, Yanhong Wang, et al. (+5) Chengchuang Song, Min Lai, Chunlei Zhang, Xingtang Fang, Xi Chen |
11 |
[GO] |
2023―Sep―09 |
Biomarkers of oxidative stress and inflammation in subjects with COVID-19: Characterization and prognosis of the disease |
Paola Mayara Valente Coronel, Indiara Correia Pereira, Denise Caroline Luiz Soares Basilio, Isabelly Teixeira Espinoça, Kamylla Fernanda Souza de Souza, Rafael Seiji Nakano Ota, et al. (+5) Eliane Borges de Almeida, Edgar Julian Paredes-Gamero, Danilo Wilhelm Filho, Renata Trentin Perdomo, Eduardo Benedetti Parisotto |
12 |
[GO] |
2023―Sep―01 |
Comparison of heterologous prime-boost immunization strategies with DNA and recombinant vaccinia virus co-expressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus in pigs |
Hewei Zhang, Jingqiang Ren, Jiachen Li, Chongkai Zhai, Fuchao Mao, Shaozhe Yang, et al. (+3) Qingwei Zhang, Zhongyu Liu, Xiuhong Fu |
13 |
[GO] |
2023―Aug―10 |
Exploring the role of tryptophanyl-tRNA synthetase and associations with inflammatory markers and clinical outcomes in COVID-19 patients: A case-control study |
Nastaran Najimi, Hamid Zahednasab, Mohammad Farahmand, Ali Fouladvand, Golamreza Talei, Behnaz Bouzari, et al. (+2) Sayyad Khanizadeh, Sajad Karampoor |
14 |
[GO] |
2023―Jul―05 |
Correlations between serum leptin levels and classical biomarkers in SARS-CoV-2 infection, in critically ill patients |
Loredana Camelia Boicean, Rares Mircea Birlutiu, Victoria Birlutiu |
15 |
[GO] |
2023―Feb―02 |
Prevalence of bovine coronavirus in cattle in China: A systematic review and meta-analysis |
Hong-Li Geng, Xiang-Zhu Meng, Wei-Lan Yan, Xiao-Man Li, Jing Jiang, Hong-Bo Ni, Wen-Hua Liu |
16 |
[GO] |
2023―Jan―20 |
Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro |
Olaposi Omotuyi, Olusina M. Olatunji, Oyekanmi Nash, Babatunji Oyinloye, Opeyemi Soremekun, Ayodeji Ijagbuji, Segun Fatumo |
17 |
[GO] |
2022―Dez―13 |
Emergent crisis of antibiotic resistance: A silent pandemic threat to 21st century |
Fatima Akram, Memoona Imtiaz, Ikram ul Haq |
18 |
[GO] |
2022―Okt―15 |
Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals |
Dinesh Kumar, Ramesh Pandit, Sonal Sharma, Janvi Raval, Zarna Patel, Madhvi Joshi, Chaitanya G. Joshi |
19 |
[GO] |
2022―Okt―13 |
Novel coronavirus mutations: Vaccine development and challenges |
Wan-Rong Luo, Xiao-Min Wu, Wei Wang, Jun-Ling Yu, Qing-Qing Chen, Xue Zhou, et al. (+5) Xin'er Huang, Hai-Feng Pan, Zhi-Rong Liu, Yong Gao, Jun He |
20 |
[GO] |
2022―Sep―30 |
Investigation of hemogram, oxidative stress, and some inflammatory marker levels in neonatal calves with escherichia coli and coronavirus diarrhea |
Omer Aydin, Nergis Ulas, Aydin Genc, Sümeyye Baysal, Ozge Kandemir, Mustafa Sinan Aktas |
21 |
[GO] |
2022―Sep―26 |
Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells |
Sara Ahmadi Badi, Amin Malek, Alessandro Paolini, Mahya Rouhollahi Masoumi, Seyed Amirhesam Seyedi, Amir Amanzadeh, et al. (+3) Andrea Masotti, Shohreh Khatami, Seyed Davar Siadat |
22 |
[GO] |
2022―Sep―19 |
The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
Mehrdad Mosadegh, Aref Khalkhali, Yousef Erfani, Manije Nezamdoost |
23 |
[GO] |
2022―Sep―15 |
Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis |
Masoud Keikha, Mohsen Karbalaei |
24 |
[GO] |
2022―Sep―02 |
Efficacy of COVID-19 vaccines |
Mohamed J. Saadh, Saif Aldeen Jaber |
25 |
[GO] |
2022―Aug―24 |
Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model |
Hossein Farshidi, Narges Farshidi, Tayebeh Ghaedi, Mehdi Hassaniazad, Ebrahim Eftekhar, Mohammad Reza Asadi Karam, et al. (+4) Behzad Shahbazi, Hamed Gouklani, Mehdi Kalani, Khadijeh Ahmadi |
26 |
[GO] |
2022―Aug―23 |
Evaluating the ability of the NLHA2 and artificial neural network models to predict COVID-19 severity, and comparing them with the four existing scoring systems |
Yue Dong, Kai Wang, Xu Zou, Xiaoping Tan, Yi Zang, Xinyu Li, et al. (+6) Xiaoting Ren, Desheng Xie, Zhijun Jie, Xiaohua Chen, Yingying Zeng, Jindong Shi |
27 |
[GO] |
2022―Aug―10 |
Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach |
Eman Alshawaf, Maha M. Hammad, Sulaiman K. Marafie, Hamad Ali, Fahd Al-Mulla, Jehad Abubaker, Anwar Mohammad |
28 |
[GO] |
2022―Aug―07 |
Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm |
Tahereh Zeinali, Niloofar Faraji, Farahnaz Joukar, Mohammadali Khan Mirzaei, Hossnieh Kafshdar Jalali, Mohammad Shenagari, Fariborz Mansour-Ghanaei |
29 |
[GO] |
2022―Aug―06 |
Unique mutations in SARS-CoV-2 omicron subvariants' non-spike proteins: Potential impact on viral pathogenesis and host immune evasion |
Anamica Hossain, Shammi Akter Trishna, Alfi Anjum Rashid, Sabik Khair, A.S.M. Rubayet Ul Alam |
30 |
[GO] |
2022―Jul―31 |
Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2 |
Mahtab Moshref Javadi, Mozhgan Taghdisi Hosseinzadeh, Neda Soliemani, Foad Rommasi |
31 |
[GO] |
2022―Jul―21 |
Moraxella occupied the largest proportion in the nasal microbiome in healthy children, which potential protect them from COVID-19 |
Xia Yu, Li Wang, XueMei Zheng, Yizhou Wen, Zhirong Zhang, Lingxia Fan, et al. (+4) Qin Zhou, Xiao Yang, Binqian Xue, Yonghong Lin |
32 |
[GO] |
2022―Jun―25 |
ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms |
Eric Pereira, Stela Felipe, Raquel de Freitas, Valdevane Araújo, Paula Soares, Jannison Ribeiro, et al. (+6) Luiz Henrique dos Santos, Juliana Osório Alves, Natália Canabrava, Mauricio van Tilburg, Maria Izabel Guedes, Vânia Ceccatto |
33 |
[GO] |
2022―Jun―08 |
Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study |
Rahimasoom Reza, Tanmoy Dutta, Nabajyoti Baildya, Narendra Nath Ghosh, Abdul Ashik Khan, Rajesh Kumar Das |
34 |
[GO] |
2022―Jun―08 |
The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach |
Prashant Ranjan, Chandra Devi, Kaaviyapriya Arulmozhi Devar, Parimal Das |
35 |
[GO] |
2022―Jun―08 |
Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran |
Mona Sadat Larijani, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Mohammad Banifazl, Anahita Bavand, Afsaneh Karami, et al. (+2) Fatemeh Asgari Shokooh, Amitis Ramezani |
36 |
[GO] |
2022―Mai―30 |
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system |
Madhura Punekar, Manas Kshirsagar, Chaitanya Tellapragada, Kanchankumar Patil |
37 |
[GO] |
2022―Mai―29 |
Comparison of pathogenicity of different subgenotype porcine reproductive and respiratory syndrome viruses isolated in China |
Jie Zhang, Juan Bai, Yangyang Sun, Xing Liu, Yanni Gao, Xianwei Wang, et al. (+2) Yuanqi Yang, Ping Jiang |
38 |
[GO] |
2022―Mai―18 |
SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study) |
Faezeh Hajazadeh, Sayyad Khanizadeh, Hamidreza Khodadadi, Yaser Mokhayeri, Mehdi Ajorloo, Asra Malekshahi, Ezatoallah Heydari |
39 |
[GO] |
2022―Mai―15 |
The association of decreased HLA-G+ immune cell frequencies with critical COVID-19 patients |
Somayeh Ramzannezhad, Mona Tarighi, Mousa Mohammadnia-Afrouzi, Soh Aghapour, Mojgan Bagherzadeh, Zahra Ahmadnia, et al. (+4) Akramossadat Hosseini, Mostafa Javanian, Housein Ghorbani, Mehdi Shahbazi |
40 |
[GO] |
2022―Apr―22 |
Detection and molecular characteristics of canine coronavirus in Chengdu city, Southwest China from 2020 to 2021 |
Xue Sha, Yan Li, Jian Huang, Qun Zhou, Xin Song, Bin Zhang |
41 |
[GO] |
2022―Apr―09 |
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia |
Mahzad Erami, Omid Raiesi, Mansooreh Momen-Heravi, Muhammad Ibrahim Getso, Mojtaba Fakhrehi, Narges Mehri, et al. (+4) Mohammad Yarahmadi, Sasan Amiri, Vahid Raissi, Seyed Jamal Hashemi |
42 |
[GO] |
2022―Apr―02 |
Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2 |
B. Uma Reddy, Nanda Kishore Routhu, Anuj Kumar |
43 |
[GO] |
2022―Mrz―28 |
NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy |
Rosa Giugliano, Assunta Sellitto, Carlo Ferravante, Teresa Rocco, Ylenia D'Agostino, Elena Alexandrova, et al. (+9) Jessica Lamberti, Domenico Palumbo, Massimiliano Galdiero, Emilia Vaccaro, Pasquale Pagliano, Alessandro Weisz, Giorgio Giurato, Gianluigi Franci, Francesca Rizzo |
44 |
[GO] |
2022―Mrz―25 |
Accuracy of clustered regularly interspaced short palindromic repeats (CRISPR) to diagnose COVID-19, a meta-analysis |
Song Wang, Jiayi Hu, Chuanying Sui, Guangliang He, Zihan Qu, Xiaofei Chen, et al. (+3) Yashan Wang, Dingjie Guo, Xin Liu |
45 |
[GO] |
2022―Mrz―22 |
Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection |
S.J. Aditya Rao, Nandini P. Shetty |
46 |
[GO] |
2022―Mrz―12 |
Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study |
Ladan Ghadami, Mehrdad Hasibi, Ali Asadollahi-Amin, Behzad asanjarani, Mohammad Farahmand, Hamed Abdollahi |
47 |
[GO] |
2022―Feb―10 |
Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2 |
Khashayar Shahin, Lili Zhang, Mohammad Hossein Mehraban, Jean-Marc Collard, Abolghasem Hedayatkhah, Mojtaba Mansoorianfar, et al. (+2) Abbas Soleimani-Delfan, Ran Wang |
48 |
[GO] |
2022―Jan―26 |
The effect of IGF-1 plasma concentration on COVID-19 severity |
Ebrahim Hazrati, Mohammad Gholami, Ramin Hamidi Farahani, Khodayar Ghorban, Morteza Ghayomzadeh, Negin Hosseini Rouzbahani |
49 |
[GO] |
2022―Jan―19 |
Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India |
Pushpendra Singh, Kuldeep Sharma, Priyanka Singh, Anudita Bhargava, Sanjay Singh Negi, Pratibha Sharma, et al. (+4) Mayuri Bhise, Manish Kumar Tripathi, Atul Jindal, Nitin M. Nagarkar |
50 |
[GO] |
2022―Jan―15 |
Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions |
Yasemin Genç Bahçe, Ömer Acer, Osman Özüdoğru |
51 |
[GO] |
2021―Nov―20 |
The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasma gondii |
Kevin Roe |
52 |
[GO] |
2021―Nov―18 |
SARS-CoV-2 Re-infection rate in Iranian COVID-19 cases within one-year follow-up |
Mostafa Salehi-Vaziri, Mohammad Hassan Pouriayevali, Fatemeh Fotouhi, Tahmineh Jalali, Mohammad Banifazl, Behrokh Farahmand, et al. (+12) Mona Sadat Larijani, Zahra Ahmadi, Zahra Fereydouni, Mahsa Tavakoli, Afsaneh Karami, Sanam Azad-Manjiri, Parastoo Yektay Sanati, Sarah Dahmardeh, Amir Hesam Nemati, Marzyie Sajadi, Setareh Kashanian, Amitis Ramezani |
53 |
[GO] |
2021―Okt―13 |
SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth |
John M. Halley, Despoina Vokou, Georgios Pappas, Ioannis Sainis |
54 |
[GO] |
2021―Okt―13 |
Investigating the conformational dynamics of SARS-CoV-2 NSP6 protein with emphasis on non-transmembrane 91-112 & 231-290 regions |
Amit Kumar, Prateek Kumar, Kumar Udit Saumya, Rajanish Giri |
55 |
[GO] |
2021―Sep―20 |
Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19 |
Noor T. Al-Bayatee, Ali H. Ad'hiah |
56 |
[GO] |
2021―Sep―13 |
An evidence of microalgal peptides to target spike protein of COVID-19: In silico approach |
Davoodbasha MubarakAli, Jaulikar Mohamed Saalis, Raghunathan Sathya, Navabshan Irfan, Jung-Wan Kim |
57 |
[GO] |
2021―Aug―28 |
HantavirusesDB: Vaccinomics and RNA-based therapeutics database for the potentially emerging human respiratory pandemic agents |
Abbas Khan, Shahzeb Khan, Sajjad Ahmad, Zeeshan Anwar, Zahid Hussain, Muhammad Safdar, et al. (+7) Muhammad Rizwan, Muhammad Waseem, Abid Hussain, Muhammad Akhlaq, Taimoor Khan, Syed Shujait Ali, Dong-Qing Wei |
58 |
[GO] |
2021―Jul―30 |
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach |
S.T.R. Moolamalla, Rami Balasubramanian, Ruchi Chauhan, U. Deva Priyakumar, P.K. Vinod |
59 |
[GO] |
2021―Jul―26 |
Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro |
Fuxiao Liu, Jiahui Lin, Qianqian Wang, Hu Shan |
60 |
[GO] |
2021―Jul―24 |
Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection |
Suresh Kumar Kali, Peter Dröge, Priyatharshini Murugan |
61 |
[GO] |
2021―Jul―21 |
Transcriptomic profiling reveals different innate immune responses in primary alveolar macrophages infected by two highly homologous porcine reproductive and respiratory syndrome viruses with distinct virulence |
Shubin Li, Xinshuai Li, Ming Qiu, Jixiang Li, Yanzhao Xiao, Hong Lin, et al. (+3) Wanglong Zheng, Jianzhong Zhu, Nanhua Chen |
62 |
[GO] |
2021―Jun―24 |
Daytime variation in SARS-CoV-2 infection and cytokine production |
Aïssatou Bailo Diallo, Gay Laetitia, Coiffard Benjamin, Leone Marc, Mezouar Soraya, Mege Jean-Louis |
63 |
[GO] |
2021―Jun―19 |
Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo |
Zhihao Chen, Xi Wang, Liubing Li, Mingxiao Han, Min Wang, Ziyuan Li, et al. (+4) Xiaolu Xie, Hong Du, Zonggang Xie, Haifang Zhang |
64 |
[GO] |
2021―Jun―18 |
Potential biomarkers for the early prediction of SARS-COV-2 disease outcome |
Vignesh Mariappan, P.S. Manoharan, Pajanivel R, Lokesh Shanmugam, S.R. Rao, Agieshkumar Balakrishna Pillai |
65 |
[GO] |
2021―Jun―10 |
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions |
Kundlik Gadhave, Prateek Kumar, Ankur Kumar, Taniya Bhardwaj, Neha Garg, Rajanish Giri |
66 |
[GO] |
2021―Jun―04 |
Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease |
HariOm Singh, Amita Singh, Abdul Arif Khan, Vivek Gupta |
67 |
[GO] |
2021―Jun―01 |
Potential association of COVID-19 and ABO blood group: An Indian study |
Iti Garg, Swati Srivastava, Vikas Dogra, Mona Bargotya, Sonali Bhattar, Utkarsh Gupta, et al. (+8) Shruti Jain, Javid Hussain, Anju A. Hembrom, Nilanjana Ghosh, Vinay Kumar, Bhuvnesh Kumar, Rajeev Varshney, Lilly Ganju |
68 |
[GO] |
2021―Mai―29 |
Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain |
Khalid Mubarak Bindayna, Abdel Halim Abdel Fattah Salem Deifalla, Hicham Ezzat Mohamed Mokbel |
69 |
[GO] |
2021―Mai―24 |
Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study |
Prem Prakash Kushwaha, Atul Kumar Singh, Kumari Sunita Prajapati, Mohd Shuaib, Sanjay Gupta, Shashank Kumar |
70 |
[GO] |
2021―Mai―19 |
Detection of SARS-CoV-2 virus using an alternative molecular method and evaluation of biochemical, hematological, inflammatory, and oxidative stress in healthcare professionals |
Carla Marcelino Trassante, Victor dos Santos Barboza, Liziane dos Santos Rocha, Paulo Maximiliano Correa, Cristiane Luchese, Ethel Antunes Wilhelm, et al. (+5) Claudio Martin Pereira de Pereira, Matheus Dellaméa Baldissera, Virginia Cielo Rech, Janice Luehring Giongo, Rodrigo de Almeida Vaucher |
71 |
[GO] |
2021―Mai―11 |
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies |
Aadil Khursheed, Vikrant Jain, Ajaz Rasool, Manzoor A. Rather, Nisar Ahmad Malik, Aabid Hussain Shalla |
72 |
[GO] |
2021―Mai―04 |
Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis |
M. Nazmul Hoque, Salma Akter, Israt Dilruba Mishu, M. Rafiul Islam, M. Shaminur Rahman, Masuda Akhter, et al. (+6) Israt Islam, Mehedi Mahmudul Hasan, Md. Mizanur Rahaman, Munawar Sultana, Tofazzal Islam, M. Anwar Hossain |
73 |
[GO] |
2021―Mai―01 |
Analysis of pathogens and risk factors of secondary pulmonary infection in patients with COVID-19 |
Haicheng Tang, Zhangyan Zhao, Xiaolin Zhang, Lei Pan, Qingguo Wu, Mei Wang, et al. (+2) Yunbin Zhang, Feng Li |
74 |
[GO] |
2021―Apr―29 |
Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro |
Xiangjun Wang, Jiayu Lu, Shuai Ge, Yajing Hou, Tian Hu, Yuexin Lv, et al. (+2) Cheng Wang, Huaizhen He |
75 |
[GO] |
2021―Apr―28 |
Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19 |
Muthupandian Saravanan, Ebrahim Mostafavi, Savariar Vincent, Hadush Negash, Rajapriya Andavar, Venkatesan Perumal, et al. (+4) Namas Chandra, Selvaraju Narayanasamy, Kalishwaralal Kalimuthu, Hamed Barabadi |
76 |
[GO] |
2021―Mrz―14 |
Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus |
Behnaz Bakhshandeh, Zohreh Jahanafrooz, Ardeshir Abbasi, Matin Babaee Goli, Mahya Sadeghi, Mohammad Sadeq Mottaqi, Maryam Zamani |
77 |
[GO] |
2021―Mrz―07 |
Contribution of STAT3 to the pathogenesis of COVID-19 |
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh |
78 |
[GO] |
2021―Feb―27 |
Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review |
Masarra M. Sakr, Noha S. El Sayed, Ghadir S. El-Housseiny |
79 |
[GO] |
2021―Feb―19 |
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? |
Dounia Darif, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, Khadija Akarid |
80 |
[GO] |
2021―Feb―15 |
Variant analysis of SARS-CoV-2 genomes in the Middle East |
Khalid Mubarak Bindayna, Shane Crinion |
81 |
[GO] |
2021―Feb―05 |
Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients |
Mehdi Shahbazi, Zahra Moulana, Mahdi Sepidarkish, Mojgan Bagherzadeh, Maryam Rezanejad, Mohammad Mirzakhani, et al. (+2) Mohammad Jafari, Mousa Mohammadnia-Afrouzi |
82 |
[GO] |
2021―Jan―29 |
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study |
Abdul Ashik Khan, Nabajyoti Baildya, Tanmoy Dutta, Narendra Nath Ghosh |
83 |
[GO] |
2021―Jan―11 |
Genetic characterization of a new NSP2-deletion porcine reproductive and Respiratory Syndrome Virus in China |
Chang-zhan Xie, Zheng Wang, Zhuo Ha, Ying Zhang, Yu-biao Xie, He Zhang, et al. (+8) Fu-long Nan, Jin-yong Zhang, Guan-yu Zhao, Zhuo-xin Li, Cheng-hui Li, Cheng-dong Yu, Ping Zhang, Ning-yi Jin |
84 |
[GO] |
2020―Dez―24 |
Applicability of MuLBSTA scoring system as diagnostic and prognostic role in early warning of severe COVID-19 |
Bei Ma, Jun Gong, Yu Yang, Xuan Yao, Xiaoqin Deng, Xi Chen |
85 |
[GO] |
2020―Dez―02 |
ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease |
HariOm Singh, Ranjana Choudhari, Vijay Nema, Abdul Arif Khan |
86 |
[GO] |
2020―Dez―02 |
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options |
Shalki Choudhary, Kajal Sharma, Harpreet Singh, Om Silakari |
87 |
[GO] |
2020―Nov―23 |
Structural and functional insights into non-structural proteins of coronaviruses |
Mohammed A. Rohaim, Rania F. El Naggar, Emily Clayton, Muhammad Munir |
88 |
[GO] |
2020―Nov―16 |
An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses |
Abdul Rouf Wani, Kanchan Yadav, Aadil Khursheed, Manzoor Ahmad Rather |
89 |
[GO] |
2020―Nov―03 |
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection |
Hossein Khorramdelazad, Mohammad Hossein Kazemi, Alireza Najafi, Maryam Keykhaee, Reza Zolfaghari Emameh, Reza Falak |
90 |
[GO] |
2020―Okt―20 |
Tunicamycin, an anticancer drug and inhibitor of N- linked glycosylation proteins is reliable to treat COVID-19 |
Ali Adel Dawood, Mahmood Abduljabar Altobje |
91 |
[GO] |
2020―Okt―19 |
The emergence of a novel recombinant porcine reproductive and respiratory syndrome virus with an amino acid insertion in GP5 protein |
Zhongbao Song, Qiaoya Zhang, Ye Chen, Haiyang Shen, Guang Yang, Ping Jiang, et al. (+2) Ji-Long Chen, Li Lin |
92 |
[GO] |
2020―Okt―14 |
Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus |
Faruku Bande, Siti Suri Arshad, Mohd Hair Bejo, Abdul Rahman Omar, Hassan Moeini, Saed Khadkodae, et al. (+4) Tan Sheau Wei, Yeap Swee Keong, Yusuf Abba, Ibrahim Abubakar Anka |
93 |
[GO] |
2020―Okt―05 |
Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19 |
Hadis Fathizadeh, Sepehr Taghizadeh, Rohollah Safari, Saeid Shabestari Khiabani, Bayaz Babak, Fatemeh Hamzavi, et al. (+6) Khudaverdi Ganbarov, Silvano Esposito, Elham Zeinalzadeh, Sounkalo Dao, Şükran Köse, Hossein Samadi Kafil |
94 |
[GO] |
2020―Okt―01 |
Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease |
Soumya Basu, Balaji Veeraraghavan, Sudha Ramaiah, Anand Anbarasu |
95 |
[GO] |
2020―Sep―25 |
Genetic analysis of a porcine reproductive and respiratory syndrome virus 1 strain in China with new patterns of amino acid deletions in nsp2, GP3 and GP4 |
Qiaoya Zhang, Zhongbao Song, Ying Yu, Juan Huang, Ping Jiang, Hu Shan |
96 |
[GO] |
2020―Sep―17 |
Use of Nasoil® via intranasal to control the harmful effects of Covid-19 |
Carlos Eduardo Cuevas-Barragan, Marco Tulio Buenrostro-Nava, Gabriela Monserrat Palos- Gómez, Elisa Alejandra Ramirez-Padilla, Blanca Isabel Mendoza-Macias, Raymundo Rene Rivas-Caceres |
97 |
[GO] |
2020―Sep―09 |
Immune response in COVID-19: What do we currently know? |
Daniela Silva de Oliveira, Nayara I. Medeiros, Juliana A.S. Gomes |
98 |
[GO] |
2020―Aug―21 |
Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19 |
Maryam Tohidinia, Fatemeh Sefid |
99 |
[GO] |
2020―Aug―18 |
The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment? |
Mehran Mahooti, Seyed Mohammad Miri, Elahe Abdolalipour, Amir Ghaemi |
100 |
[GO] |
2020―Jul―20 |
Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236] |
Parismita Kalita, Aditya K. Padhi, Kam Y.J. Zhang, Timir Tripathi |
101 |
[GO] |
2020―Jul―15 |
Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis |
Ali Pormohammad, Saied Ghorbani, Behzad Baradaran, Alireza Khatami, Raymond J. Turner, Mohammad Ali Mansournia, et al. (+3) Demetrios N. Kyriacou, Juan-Pablo Idrovo, Nathan C. Bahr |
102 |
[GO] |
2020―Jul―11 |
Identification of enterobacteria in viscera of pigs afflicted with porcine reproductive and respiratory syndrome and other viral co-infections |
Ge Zhao, Lujie Zhang, Charles Li, Jianmei Zhao, Na Liu, Yuehua Li, et al. (+2) Junwei Wang, Liheng Liu |
103 |
[GO] |
2020―Jun―30 |
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease |
Emanuelle Machado Marinho, João Batista de Andrade Neto, Jacilene Silva, Cecília Rocha da Silva, Bruno Coelho Cavalcanti, Emmanuel Silva Marinho, Hélio Vitoriano Nobre Júnior |
104 |
[GO] |
2020―Mai―28 |
A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? |
Mani Divya, Sekar Vijayakumar, Jingdi Chen, Baskaralingam Vaseeharan, Esteban F. Durán-Lara |
105 |
[GO] |
2020―Mai―05 |
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) |
Ehsaneh Khodadadi, Parham Maroufi, Ehsan Khodadadi, Isabella Esposito, Khudaverdi Ganbarov, Silvano Espsoito, et al. (+3) Mehdi Yousefi, Elham Zeinalzadeh, Hossein Samadi Kafil |
106 |
[GO] |
2020―Mai―04 |
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 |
Parismita Kalita, Aditya K. Padhi, Kam Y.J. Zhang, Timir Tripathi |
107 |
[GO] |
2020―Apr―25 |
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect |
Julien Andreani, Marion Le Bideau, Isabelle Duflot, Priscilla Jardot, Clara Rolland, Manon Boxberger, et al. (+5) Nathalie Wurtz, Jean-Marc Rolain, Philippe Colson, Bernard La Scola, Didier Raoult |
108 |
[GO] |
2020―Apr―18 |
Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018-2019 |
Hai-Jian He, Wenyan Zhang, Jiawei Liang, Meng Lu, Ruyi Wang, Gairu Li, et al. (+4) Jia-Wei He, Jun Chen, Gang Xing, Ye Chen |
109 |
[GO] |
2020―Mrz―31 |
Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky |
110 |
[GO] |
2020―Mrz―20 |
Genetic signatures of the immune-escaping type 2 porcine reproductive and respiratory syndrome virus in farms with a robust vaccination program |
Wimontiane Saenglub, Tippawan Jantafong, Chatthapon Mungkundar, Narin Romlamduan, Sunan Pinitkiatisakul, Porntippa Lekcharoensuk |
111 |
[GO] |
2020―Feb―29 |
Porcine reproductive and respiratory syndrome virus up-regulates sialoadhesin via IFN-STAT signaling to facilitate its infection |
Yingqi Liu, Rui Li, Yuyang Zhang, Songlin Qiao, Xin-xin Chen, Gaiping Zhang |
112 |
[GO] |
2019―Dez―18 |
Characterization of porcine reproductive and respiratory syndrome virus (ORF5 RFLP 1-7-4 viruses) in northern China |
Changzhan Xie, Zhuo Ha, Fulong Nan, Ying Zhang, Han Zhang, Jinfeng Li, et al. (+7) Ping Zhang, Jicheng Han, He Zhang, Xinyu Zhuang, Jinyong Zhang, Huijun Lu, Ningyi Jin |